AAAAAA
Results: 1-25/40
Authors:
EARY JF
CONRAD EU
BRUCKNER JD
FOLPE A
HUNT KJ
MANKOFF DA
HOWLETT AT
Citation: Jf. Eary et al., QUANTITATIVE [F-18] FLUORODEOXYGLUCOSE POSITRON-EMISSION-TOMOGRAPHY IN PRETREATMENT AND GRADING OF SARCOMA, Clinical cancer research, 4(5), 1998, pp. 1215-1220
Authors:
EARY JF
CONRAD EU
BRUCKNER JD
FOLPE A
HUNT KJ
MANKOFF DA
HOWLETT AT
Citation: Jf. Eary et al., QUANTITATIVE [F-18] FLUORODEOXYGLUCOSE POSITRON-EMISSION-TOMOGRAPHY IN PRETREATMENT AND GRADING OF SARCOMA, Clinical cancer research, 4(5), 1998, pp. 1215-1220
Authors:
SPROUSE JT
FOLPE AL
SCHMIDT RA
EARY JF
Citation: Jt. Sprouse et al., PET-MRFDG AS A PREDICTOR OF PATHOLOGICAL GRADE AND OTHER PROGNOSTIC VARIABLES IN BONE AND SOFT-TISSUE SARCOMA, Modern pathology, 11(1), 1998, pp. 15-15
Authors:
LIU SY
EARY JF
PETERSDORF SH
MARTIN PJ
MALONEY DG
APPELBAUM FR
MATTHEWS DC
BUSH SA
DURACK LD
FISHER DR
GOOLEY TA
BERNSTEIN ID
PRESS OW
Citation: Sy. Liu et al., FOLLOW-UP OF RELAPSED B-CELL LYMPHOMA PATIENTS TREATED WITH IODINE-131-LABELED ANTI-CD20 ANTIBODY AND AUTOLOGOUS STEM-CELL RESCUE, Journal of clinical oncology, 16(10), 1998, pp. 3270-3278
Authors:
EUBANK WB
MANKOFF DA
SCHMIEDL UP
WINTER TC
FISHER ER
OLSHEN AB
GRAHAM MM
EARY JF
Citation: Wb. Eubank et al., IMAGING OF ONCOLOGIC PATIENTS - BENEFIT OF COMBINED CT AND FDG PET INTHE DIAGNOSIS OF MALIGNANCY, American journal of roentgenology, 171(4), 1998, pp. 1103-1110
Authors:
MANKOFF DA
SHIELDS AF
GRAHAM MM
LINK JM
EARY JF
KROHN KA
Citation: Da. Mankoff et al., KINETIC-ANALYSIS OF 2-[CARBON-11]THYMIDINE PET IMAGING STUDIES - COMPARTMENTAL MODEL AND MATHEMATICAL-ANALYSIS, The Journal of nuclear medicine, 39(6), 1998, pp. 1043-1055
Authors:
EARY JF
MANKOFF DA
DUNNWALD LK
BYRD D
ANDERSON B
YEUNG R
MOC R
Citation: Jf. Eary et al., SENTINEL NODE LYMPHATIC MAPPING FOR BREAST-CANCER - APPLICATION TO A DIVERSE PATIENT POPULATION, The Journal of nuclear medicine, 39(5), 1998, pp. 85-85
Authors:
EARY JF
MANKOFF DA
SPENCE AM
OSULLIVAN F
KROHN KA
Citation: Jf. Eary et al., QUANTITATION OF BRAIN-TUMOR PROLIFERATION WITH [C-11] THYMIDINE PET IMAGING, The Journal of nuclear medicine, 39(5), 1998, pp. 201-201
Authors:
EARY JF
CONRAD EU
BRUCKNER J
VERNON C
HUNT K
Citation: Jf. Eary et al., FDG PET ASSESSMENT OF TUMOR RESPONSE IN SARCOMA, The Journal of nuclear medicine, 39(5), 1998, pp. 371-371
Authors:
WILSON DC
EARY JF
CONRAD EU
BRUCKNER J
HUNT KJ
RASEY JS
Citation: Dc. Wilson et al., QUANTITATIVE FMISO PET ANALYSIS OF HYPOXIA IN SOFT-TISSUE SARCOMAS AND CORRELATION WITH FDG UPTAKE, The Journal of nuclear medicine, 39(5), 1998, pp. 857-857
Authors:
SHONER SC
EARY JF
KROHN KA
Citation: Sc. Shoner et al., IMPROVED SEPARATIONS IN THE PRODUCTION OF YTTRIUM-86 FOR POSITRON-EMISSION-TOMOGRAPHY, The Journal of nuclear medicine, 39(5), 1998, pp. 1026-1026
Authors:
EARY JF
MANKOFF DA
Citation: Jf. Eary et Da. Mankoff, TUMOR METABOLIC RATES IN SARCOMA USING FDG PET, The Journal of nuclear medicine, 39(2), 1998, pp. 250-254
Authors:
SHIELDS AF
MANKOFF DA
LINK JM
GRAHAM MM
EARY JF
KOZAWA SM
ZHENG M
LEWELLEN B
LEWELLEN TK
GRIERSON JR
KROHN KA
Citation: Af. Shields et al., CARBON-11-THYMIDINE AND FDG TO MEASURE THERAPY RESPONSE, The Journal of nuclear medicine, 39(10), 1998, pp. 1757-1762
Authors:
SPROUSE JT
FOLPE AL
SCHMIDT RA
EARY JF
Citation: Jt. Sprouse et al., PET-MRFDG AS A PREDICTOR OF PATHOLOGICAL GRADE AND OTHER PROGNOSTIC VARIABLES IN BONE AND SOFT-TISSUE SARCOMA, Laboratory investigation, 78(1), 1998, pp. 67-67
Authors:
YUAN C
PETTY C
OBRIEN KD
HATSUKAMI TS
EARY JF
BROWN BG
Citation: C. Yuan et al., IN-VITRO AND IN-SITU MAGNETIC-RESONANCE-IMAGING SIGNAL FEATURES OF ATHEROSCLEROTIC PLAQUE-ASSOCIATED LIPIDS, Arteriosclerosis, thrombosis, and vascular biology, 17(8), 1997, pp. 1496-1503
Authors:
EARY JF
KROHN KA
PRESS OW
DURACK L
BERNSTEIN ID
Citation: Jf. Eary et al., IMPORTANCE OF PRETREATMENT RADIATION ABSORBED DOSE ESTIMATION FOR RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA, Nuclear medicine and biology, 24(7), 1997, pp. 635-638
Authors:
MANKOFF DA
TEWSON TJ
EARY JF
Citation: Da. Mankoff et al., ANALYSIS OF BLOOD CLEARANCE AND LABELED METABOLITES FOR THE ESTROGEN-RECEPTOR TRACER [F-18] 16-ALPHA-FLUORESTRADIOL (FES), Nuclear medicine and biology, 24(4), 1997, pp. 341-348
Authors:
MANKOFF DA
THOMPSON JA
GOLD P
EARY JF
GUINEE DG
SAMLOWSKI WE
Citation: Da. Mankoff et al., IDENTIFICATION OF INTERLEUKIN-2-INDUCED COMPLETE RESPONSE IN METASTATIC RENAL-CELL CARCINOMA BY FDG PET DESPITE RADIOGRAPHIC EVIDENCE SUGGESTING PERSISTENT TUMOR, American journal of roentgenology, 169(4), 1997, pp. 1049-1050
Authors:
TEWSON TJ
MANKOFF DA
EARY JF
Citation: Tj. Tewson et al., METABOLISM AND CLEARANCE OF [F-18] 16-ALPHA-FLUOROESTRADIOL (FES) IN PATIENTS, The Journal of nuclear medicine, 38(5), 1997, pp. 759-759
Authors:
EARY JF
CONRAD EU
MANKOFF DA
BRUCKNER JA
Citation: Jf. Eary et al., FDG PET IN GRADING OF SOFT-TISSUE AND BONE SARCOMAS, Radiology, 205, 1997, pp. 339-339
Authors:
MATTHEWS DC
APPELBAUM FR
EARY JF
MITCHELL D
PRESS OW
BERNSTEIN ID
Citation: Dc. Matthews et al., PHASE-I STUDY OF I-131 ANTI-CD45 ANTIBODY PLUS CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION FOR ADVANCED ACUTE-LEUKEMIA AND MYELODYSPLASTIC SYNDROME, Blood, 90(10), 1997, pp. 1854-1854
Authors:
HOWLETT AT
BRUCKNER JD
EARY JF
Citation: At. Howlett et al., THE USE OF PET IMAGING STUDIES IN THE MANAGEMENT OF A PATIENT WITH OLLIERS DISEASE, Journal of investigative medicine, 44(1), 1996, pp. 139-139
Authors:
EARY JF
KROHN KA
PRESS OW
FISHER D
BERNSTEIN ID
Citation: Jf. Eary et al., RADIOIMMUNOTHERAPY TREATMENT PLANNING BASED ON RADIATION ABSORBED DOSE OR PATIENT SIZE, The Journal of nuclear medicine, 37(5), 1996, pp. 162-162
Authors:
SHIELDS AF
MANKOFF DA
LINK JM
GRAHAM MM
EARY JF
KOZAWA S
ZHENG M
LEWELLEN B
LEWELLEN TK
GRIERSON JR
KROHN KA
Citation: Af. Shields et al., MONITORING TUMOR RESPONSE TO CHEMOTHERAPY WITH [C-11] THYMIDINE AND FDG PET, The Journal of nuclear medicine, 37(5), 1996, pp. 259-259
Authors:
EARY JF
MANKOFF DA
CONRAD EU
BRUCKNER JB
BAVISOTTO L
Citation: Jf. Eary et al., RELATIONSHIP OF TUMOR GLUCOSE METABOLIC-RATE AND TUMOR DIFFERENTIAL UPTAKE RATIO IN SARCOMA USING FDG, The Journal of nuclear medicine, 37(5), 1996, pp. 618-618